MedTrace Logo

Sirtuin1 in COVID19 Patients

NCT04907916 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2021-06-01

No results posted yet for this study

Summary

1. Evaluate serum level of NAD,Sirtuin1,ADAM17 andPARP1 in covid19 patients
2. Investigate the correlation between measured biomarkers and each other
3. Investigate the correlation between measured biomarkers and each other and their correlation with covid19 severity and outcome which may help in the therapy and prevention of disease complication(cytokine storm)

Conditions

  • Covid19

Interventions

OTHER

SIRTUIN1

The NAD dependent deacetylase activity of Sirtuin1

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2022-08-01
Completion
2023-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04907916 on ClinicalTrials.gov